Regional fat mass by DXA: High leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 3, 2008, Pages 204-211

  Aasen, G ^a   Fagertun, H ^b   Halse, J ^a  

^a Spesialistsenteret Pilestredet Park   (Norway)

^b Capturo AS   (Norway)

Author keywords

DXA; Dyslipidaemia; Insulin resistance; Leg fat mass; Trunk fat mass

Indexed keywords

C PEPTIDE; CHOLESTEROL; FAT; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OBESITY; PATIENT REFERRAL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN RESISTANCE; LEG; MIDDLE AGED; OBESITY; ORGAN SIZE; OVERWEIGHT; POSTMENOPAUSE; RISK FACTORS;

EID: 43049101988     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701649524     Document Type: Article

References (42)

1. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-8.
2. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, et al. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 2003;158:1161-70.
3. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in Women. The Nurses' Health Study. Am J Epidemiol 1997;145:614-19.
4. Lissner L, Bjorkelund C, Heitmann BL, Seidell JC, Bengtsson C. Larger hip circumference independently predicts health and longevity in a Swedish female cohort. Obes Res 2001;9:644-9.
5. Heitmann BL, Frederiksen P, Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004;12:482-87.
6. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 2003;77:1192-7.
7. Seidell JC, Pérusse L, Deprés J-P, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk: the Quebec family study. Am J Clin Nutr 2001;74:315-21.
8. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab study. Int J Obes Relat Metab Disord 2004;28:402-9.
9. Ley CJ, Lees B, Stevenson JC. Sex- and menopause associated changes in body-fat distribution. Am J Clin Nutr 1992;55:950-4.
10. Williams MJ, Hunter GR, Kekes-Szabo T, Snyder S, Treuth MS. Regional fat distribution in women and risk of cardiovascular disease. Am J Clin Nutr 1997;5:855-60.
11. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contribution of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002;282:E1023-8.
12. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 2005;90:4573-8.
13. Tatsukawa M, Kurokawa M, Tamari Y, Yoshimatsu H, Sakata T. Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenicity. In Japanese. Proc Soc Exp Bio Med 2000;223:156-62.
14. Tank LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 2003;107:1626-31.
15. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 2004;27:372-7.
16. Snijder MB, Visser M, Dekker JM, Gooodpaster BH, Harris TB, Kritechevsky SB, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The health ABC study. Diabetologia 2005;48:301-8.
17. Gauiller J-M, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004;79:1118-25.
18. Aasen G, Fagertun H, Halse J. Body composition analysis by dual X-ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments. Scand J Clin Lab Invest 2006;66:659-66.
19. Matthews DR, Hosker JP, Rudenski AS, Maylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
20. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianai F, Zenner MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57-63.
21. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
22. Yokoyama H, Emoto M, Fujiwara S, Motomyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal weight range and moderately obese type 2 diabetic patients. Diabetes Care 2003;26:2426-32.
23. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Jarvinen HY, Van Haften T, et al. Use of the oral tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
24. Friedewald WR, Levy RI, Fredichson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
25. Goodpaster BH, Thaete FL, Kelly DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000;71:885-92.
26. Munoz J, Derstine A, Gower BA. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res 2002;10:424-31.
27. Shand BI, Scott RS, Elder PA, George PM. Plasme adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-53.
28. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004;53:585-90.
29. Kantartzis K, Fritsche, Tschritter O, Thamer C, Haap M, Schäfer, et al. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 2005;13:1683-91.
30. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-43.
31. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponctinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
32. Behre CJ, Brohall G, Hulthe J, Fagerberg B. Serum adiponectin in a population sample of 64-year-old women in relation to glucose tolerance, family history of diabetes, autoimmunity, insulin sensitivity, C-peptide, and inflammation. Metabolism 2006;55:188-94.
33. Hanley AJG, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in non-diabetic Hispanic and African Americans. J Clin Endocrinol Metab. (DOI: 10.1210/jc.2006-2614.)
34. Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin Endocrinol 2001;5:447-54.
35. Landin K, Lönneroth P, Krotkiewski M, Holm G, Smith U. Increased insulin resistance and fat cell lipoplysis in obese but not lean women with high waist/hip ratio. Eur J Clin Invest 1990;20:530-5.
36. Bos G, Snijder MB, Nijpels G, Dekker JM, Coen DA, Bouter LM, et al. Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn study. Obes Res 2005;3:817-22.
37. Marette A, Mauriege P, Marcotte B, Atgie C, Bouchard C, Theriault C, et al. Regional variations in adipose tissue insulin action and GLUT4 transporter expression in severely obese premenopausal women. Diabetologia 1997;40:590-8.
38. Sites CK, Brochu M, Tchernof A, Poehlman ET. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women. Metabolism 2001;50:835-40.
39. Ryan A, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 2002;25:127-33.
40. Hanley AJG, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance of cardiovascular disease. The San Antonio Heart Study. Diabetes Care 2002;25:1177-84.
41. Moan A, Høieggen A, Seljefloth I, Risanger T, Arnesen H, Kjeldsen S. The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and sensitivity. J Hypertens 1996;14:1093-7.
42. Huptas S, Geiss HC, Otto C, Parhofer KG. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome. Am J Cardiol 2006;98:66-9.